Related Experiment Videos
[Medical hemostasis. II. Systemic hemostatics, a critical evaluation]
1Centrale Proefdier Voorzieningen Medische Faculteit Maastricht, Biomedisch Centrum RL.
Tijdschrift Voor Diergeneeskunde
|February 1, 1989
Summary
Controlling animal hemorrhage is challenging. Antifibrinolytic agents like tranexamic acid show promise for veterinary use, warranting clinical trials to assess their effectiveness and safety in managing bleeding disorders.
Area of Science:
- Veterinary Medicine
- Hematology
- Pharmacology
Context:
- Hemorrhage control is a significant concern for veterinarians.
- Topical treatments are often insufficient for severe bleeding or hemostatic defects.
- Existing systemic hemostatic agents lack proven clinical value in veterinary practice.
Purpose:
- To explore the potential of antifibrinolytic agents for managing hemorrhage in veterinary medicine.
- To address the need for effective systemic hemostatic treatments in animals.
- To investigate the clinical efficacy and safety of antifibrinolytic drugs in veterinary patients.
Summary:
- Antifibrinolytic agents, such as tranexamic acid, are clinically effective in humans for certain bleeding conditions.
- Their mechanism of action suggests potential benefits in veterinary hemostasis.
- Clinical trials are needed to evaluate these agents for severe bleeding and perioperative hemorrhage in animals.
Impact:
- This research could lead to new, effective treatments for animal hemorrhage.
- Improved hemostatic control can enhance patient outcomes and reduce mortality.
- Successful implementation of antifibrinolytics could offer a valuable alternative to blood transfusions.